So far, the first quarter of 2017 is looking good for NewCo life science platform companies in Boston.  908 Devices, a Boston based pioneer of small and elegantly systems for chemical and biomolecule analysis, announced a sales partnership with Thermo Fisher to sell their ZipChip™ as a front-end to Thermo’s mass spectrometry (MS) instruments. They followed that up by closing a $20M growth equity round in March. RedShift BioAnalytics, based in Burlington, MA, completed a Series C raise of $11M with strategic investments from Water...

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon

© 2020 The Sonder Group